Britain starts accelerated review for AstraZeneca’s potential Covid-19 vaccine
AstraZeneca and Pfizer are among leaders in the race to develop a vaccine for the coronavirus
01 November 2020 - 16:27
Bengaluru — UK pharmaceutical group AstraZeneca says Britain’s health regulator had started an accelerated review of its potential coronavirus vaccine.
An AstraZeneca spokesperson said on Sunday that the MHRA’s (Medicines and Healthcare Products Regulatory Agency (MHRA) had begun a rolling review of our potential Covid-19 vaccine”...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.